Integrin

整合素 (Integrin) 是针对各种细胞外基质的异二聚体粘附受体家族,一直被认为是卵巢癌发展和进展的关键驱动因素。整合素家族的许多基于 RGD 的成员,包括 α5β1 和 αvβ3 或 αvβ5 整合素,在侵袭性卵巢肿瘤中显著升高。这些粘附受体似乎在卵巢肿瘤生长或转移进展期间促进细胞粘附、存活、运动和侵袭。重要的是,这些整合素的功能强烈依赖于粘着斑激酶 (FAK) 的激活及其下游信号传导,包括 PI3K/Akt 和 Ras/MAPK 依赖性通路。

整合素是跨膜蛋白,是细胞-细胞外基质 (ECM) 和细胞-细胞粘附的主要受体。这些分子的调节,特别是 αv 整合素家族,对多器官和疾病状态下的纤维化具有深远的影响。根据多项研究,整合素 αvβ3、αvβ5、αvβ6 和 αvβ8 已知可通过激活潜在转化生长因子 (TGF)-β 在纤维化的临床前模型中调节纤维化过程。

每个整合素通常由一个 α 亚基(已知存在 18 种类型)和一个 β 亚基(已知存在 8 种类型)非共价配对形成。迄今为止,已鉴定出 24 种不同的异二聚体。αv 亚基可与 β1、β3、β5、β6 或 β8 亚基形成异二聚体,β1 可与从 α1 到 α11 和 αv 的许多不同 α 亚基结合,这表明并非所有理论上可能的 α 和亚基对都能形成。有趣的是,TGF-β 的激活似乎是多种 αv 整合素的共同功能。

Integrins, a family of heterodimeric adhesion receptors for diverse extracellular matrices, have consistently been implicated as crucial drivers of ovarian cancer development and progression. A number of the RGD-based members of the integrin family, including α5β1, and αvβ3 or αvβ5 integrins, are markedly elevated in aggressive ovarian tumors. These adhesion receptors appear to promote cell adhesion, survival, motility and invasion during ovarian tumor growth or metastatic progression. Importantly, the functions of these integrins are strongly dependent on the activation of focal adhesion kinase (FAK) and its downstream signaling, including the PI3K/Akt- and Ras/MAPK-dependent pathways.

Integrins are transmembrane proteins and are major receptors for cell-extracellular matrix (ECM) and cell-cell adhesion. Modulation of these molecules, particularly αv integrin family, has exhibited profound effects on fibrosis in multiple organ and disease state. Based on the several studies, the integrins αvβ3, αvβ5, αvβ6, and αvβ8 have been known to modulate the fibrotic process via activation of latent transforming growth factor (TGF)-β in pre-clinical models of fibrosis.

Each integrin is typically formed by the non-covalent pairing of one α subunit, of which, 18 types are known to exist, and one β subunit, of which 8 types are known to exist. Together, 24 distinct heterodimers have been identified to date. The αv subunit can form heterodimers with the β1, β3, β5, β6 or β8 subunits and β1 can associate with many different α subunits from α1 to α11, and αv, indicating that not all theoretically possible α and subunit pairs form. Interestingly, the activation of TGF-β appears to be a common function of multiple αv integrins.

共 9种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
FZ1 peptide

FZ1 peptide 是一种整合素 (integrin) αvβ3 激动剂,可与整合素 αvβ3 结合并有效激活 FAK、FAK 依赖的 AKT 和 ERK1/2 信号通路,从而增强 VEGFC 诱导的内皮血管生成并加速糖尿病皮肤伤口愈合。

Agonist
99.92%
FZ1 peptide
Integrin modulator 1

Integrin modulator 1 是一种有效且选择性的 α4β1 整联蛋白激动剂,IC50 值为 9.8 nM,可通过 EC50 值为 12.9 nM 增强 α4β1 整联蛋白介导的细胞粘附。

2023788-32-9
Agonist
99.80%
Integrin modulator 1
Leukadherin-1

Leukadherin-1 是特异性白细胞表面整合素 CD11b/CD18 的激动剂,可增加 CD11b/CD18 依赖性细胞对血纤蛋白原的粘附(EC50 为 4 μM),增强白细胞对配体(如 ICAM-1)和血管内皮的粘附,从而减少白细胞跨内皮迁移和流入损伤部位,并抑制先天性炎症信号转导。

344897-95-6
Agonist
98.0%
Leukadherin-1
Leukadherin-1 (Standard)

Leukadherin-1 (Standard) 是 Leukadherin-1 的分析标准品,用于研究及分析应用;Leukadherin-1 是特异性的白细胞表面整合素 CD11b/CD18 激动剂,可增加 CD11b/CD18 依赖性细胞对血纤蛋白原的粘附(EC50 为 4 μM),并增强白细胞对配体(如 ICAM-1)和血管内皮的粘附,从而减少白细胞跨内皮迁移和流入损伤部位。

344897-95-6
Agonist
95%
Leukadherin-1 (Standard)
LT25

LT25(compound 17)是一种 α5β1 整合素激动剂,其 EC50 值为 9.9 nM。

2023788-40-9
Agonist
98.73%
LT25
Pyrintegrin

Pyrintegrin 是一种 β1 整合素 (β1-integrin) 激动剂,也是一种可促进胚胎干细胞存活的 2,4-二取代嘧啶,能增强细胞-细胞外基质 (ECM) 粘附介导的整联蛋白信号传导,可用作足细胞保护剂,并具有强大的成脂作用。

1228445-38-2
Agonist
99.71%
Pyrintegrin
α5β1 integrin agonist-1

α5β1 integrin agonist-1 是一种 α5β1 integrin 激动剂(EC50=1.30 μM),在 Jurkat/VCAM-1 黏附试验中抑制 α4β1 整合素(IC50=2.99 μM),并在表达 α5β1 integrin 的 K562 癌细胞中诱导浓度依赖性凋亡(apoptosis)及激活 caspase 3/7 通路,可用于癌症研究。

2756557-83-0
Agonist
99.67%
α5β1 integrin agonist-1
α5β1 integrin agonist-2

α5β1 integrin agonist-2(Compound 2)是一种选择性 α5β1 整合素激动剂(EC50 = 45.98 nM),可诱导整合素激活,并可用于白血病的研究。

3115530-47-4
Agonist
99.80%
α5β1 integrin agonist-2
αMβ2 integrin agonist-1

αMβ2 integrin agonist-1 (Compound 8) 是一种具有抗炎活性 (EC50=1.4 nM) 的高选择性 αMβ2整合素 (αMβ2 integrin) 激动剂,可激活整合素介导的细胞黏附及 JNK/ERK 信号通路,诱导肿瘤相关巨噬细胞极化并增强抗肿瘤T细胞免疫应答,有望用于癌症和慢性炎症性疾病 (如胰腺癌、类风湿关节炎) 的研究。

Agonist
αMβ2 integrin agonist-1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础